US 12,263,201 B2
Process to enhance the bioactivity of Ashwagandha extracts
Benny Antony, Angamaly (IN)
Assigned to ARJUNA NATURAL PRIVATE LIMITED, Alwaye (IN)
Filed by ARJUNA NATURAL PRIVATE LIMITED, Alwaye (IN)
Filed on Mar. 10, 2023, as Appl. No. 18/119,976.
Application 18/119,976 is a division of application No. 17/123,636, filed on Dec. 16, 2020, granted, now 11,638,738.
Application 16/265,440 is a division of application No. 15/326,450, granted, now 10,251,927, issued on Apr. 9, 2019, previously published as PCT/IN2016/050354, filed on Oct. 18, 2016.
Application 15/958,654 is a division of application No. 15/444,669, filed on Feb. 28, 2017, granted, now 9,987,323, issued on Jun. 5, 2018.
Application 17/123,636 is a continuation of application No. 16/265,440, filed on Feb. 1, 2019, abandoned.
Application 18/119,976 is a continuation of application No. 17/990,863, filed on Nov. 21, 2022.
Application 17/990,863 is a continuation in part of application No. 17/123,636, filed on Dec. 16, 2020, granted, now 11,638,738.
Application 17/123,636 is a continuation of application No. 15/326,450, granted, now 10,251,927, issued on Apr. 9, 2019, previously published as PCT/IN2016/050354, filed on Oct. 18, 2016.
Application 18/119,976 is a continuation in part of application No. 15/958,654, filed on Apr. 20, 2018, granted, now 10,166,266, issued on Jan. 1, 2019.
Application 15/444,669 is a continuation of application No. 15/326,450, granted, now 10,251,927, issued on Apr. 9, 2019, previously published as PCT/IN2016/050354, filed on Oct. 18, 2016.
Claims priority of application No. 5691/CHE/2015 (IN), filed on Oct. 22, 2015.
Prior Publication US 2023/0233642 A1, Jul. 27, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 36/00 (2006.01); A61K 9/14 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 9/50 (2006.01); A61K 36/185 (2006.01); A61K 36/21 (2006.01); A61K 36/23 (2006.01); A61K 36/47 (2006.01); A61K 36/48 (2006.01); A61K 36/53 (2006.01); A61K 36/534 (2006.01); A61K 36/54 (2006.01); A61K 36/67 (2006.01); A61K 36/71 (2006.01); A61K 36/81 (2006.01); A61K 36/82 (2006.01); A61K 36/87 (2006.01); A61K 36/9066 (2006.01); A61K 36/9068 (2006.01)
CPC A61K 36/81 (2013.01) [A61K 9/14 (2013.01); A61K 9/16 (2013.01); A61K 9/2081 (2013.01); A61K 9/2846 (2013.01); A61K 9/50 (2013.01); A61K 9/5026 (2013.01); A61K 9/5036 (2013.01); A61K 9/5042 (2013.01); A61K 36/185 (2013.01); A61K 36/21 (2013.01); A61K 36/23 (2013.01); A61K 36/47 (2013.01); A61K 36/48 (2013.01); A61K 36/53 (2013.01); A61K 36/534 (2013.01); A61K 36/54 (2013.01); A61K 36/67 (2013.01); A61K 36/71 (2013.01); A61K 36/82 (2013.01); A61K 36/87 (2013.01); A61K 36/9066 (2013.01); A61K 36/9068 (2013.01); A61K 2236/00 (2013.01); A61K 2236/13 (2013.01); A61K 2236/15 (2013.01); A61K 2236/33 (2013.01); A61K 2236/331 (2013.01); A61K 2236/35 (2013.01); A61K 2236/51 (2013.01)] 8 Claims
 
1. A method of enhancing bioactivity of an extract of Withania somnifera in a subject in need thereof, the method comprising administering a composition comprising an extract of Withania somnifera to the subject in need thereof, wherein the extract of Withania somnifera comprises about 30% to about 50% withanolide glycosides by weight; about 2% to about 30% saponins by weight; and about 0.001% to about 0.1% by weight of alkaloids.